VTE risk and Caprini stratification

VTE — the most serious elective surgery risk

Venous thromboembolism (VTE) — deep vein thrombosis (DVT) and its potential progression to pulmonary embolism (PE) — is the most clinically significant potential complication of abdominoplasty. While rare (incidence 0.3-1% in modern series), the consequences of unmitigated PE include death. VTE prevention is therefore not optional — it is a structured pre-operative through post-operative protocol that begins before the patient enters the operating room.

Why abdominoplasty patients are at risk

Several factors converge to elevate VTE risk in abdominoplasty:

• Prolonged surgery — 3-5 hours typical, longer for combined procedures.
• Abdominal wall manipulation — rectus plication increases intra-abdominal pressure, which can compromise venous return from the lower limbs.
• Post-operative reduced mobility — 7-14 days of significantly reduced ambulation.
• Patient demographics — abdominoplasty patients are often female, often have hormonal contraception or HRT exposure, sometimes have post-bariatric history with weight-loss-related coagulation changes.
• Compounding when combined — mommy makeover (tummy tuck + breast surgery) extends operative time and increases compounded risk.

The Caprini score — risk stratification

The Caprini score is the most widely used VTE risk stratification tool for surgical patients. It assigns weighted points across multiple risk factors:

Major risk factors (5 points each)

• Stroke within 1 month
• Hip/pelvis/leg fracture
• Acute spinal cord injury
• Multiple trauma
• Elective major lower extremity arthroplasty

3-point factors

• Age 75 years or older
• History of DVT/PE
• Family history of thrombosis
• Factor V Leiden or other thrombophilia
• Heparin-induced thrombocytopenia history

2-point factors

• Age 61-74
• Major surgery (over 45 minutes) — abdominoplasty falls here
• Laparoscopic surgery (over 45 minutes)
• Malignancy (current)
• Patient confined to bed (over 72 hours)
• Plaster cast
• Central venous access

1-point factors

• Age 41-60
• BMI over 25
• Swollen legs (current)
• Varicose veins
• Pregnancy or postpartum (less than 1 month)
• History of unexplained or recurrent spontaneous abortion
• Hormonal contraceptive or HRT
• Sepsis (less than 1 month)
• Serious lung disease (less than 1 month)
• Abnormal pulmonary function
• Acute MI
• Congestive heart failure
• History of inflammatory bowel disease
• Medical patient on bed rest

Risk category and prophylaxis

The typical abdominoplasty patient's score

A 45-year-old female with BMI 28 on hormonal contraception undergoing standard abdominoplasty:

• Age 41-60: 1
• BMI over 25: 1
• Hormonal contraceptive: 1
• Major surgery over 45 minutes: 2
• Total: 5

This is "highest risk" — chemical prophylaxis with enoxaparin plus mechanical, often extended for 7-14 days post-discharge, is appropriate.

Most abdominoplasty patients fall into the "high" or "highest" risk categories simply by virtue of the procedure itself plus typical demographic factors. Routine chemical prophylaxis is therefore standard practice in modern abdominoplasty.

The specific prophylaxis components

Mechanical — for every patient

• Sequential compression devices (SCDs) applied before induction of anaesthesia, continued during surgery and in the recovery period.
• Graduated compression stockings for the duration of reduced mobility.
• Early ambulation — first walk within 4-6 hours of surgery.

Chemical — for moderate risk and above

• Enoxaparin (low molecular weight heparin) — 40mg subcutaneous daily, started typically 6-12 hours post-operatively.
• Duration: minimum to discharge, often extended to 7-14 days for higher-risk patients.
• Self-administration training for patients continuing post-discharge.

Hormonal management

• Combined hormonal contraceptives ideally discontinued 4 weeks pre-operatively (alternative contraception arranged).
• HRT case-by-case — risks weighed against menopausal symptom impact.
• Restart timing — 4-6 weeks post-operatively typically.

Pre-operative screening

• Personal and family thrombosis history — explicit query during pre-op.
• Thrombophilia screen when family history present or personal history of unexplained thrombosis.
• D-dimer as part of pre-op panel in selected high-risk cases.

Detection — recognising VTE

Post-operative patients should be educated on warning signs:

DVT signs (typically lower limb)

• Calf or thigh swelling, often unilateral
• Calf tenderness, especially on dorsiflexion (Homan's sign — historically, but unreliable)
• Erythema or warmth over the calf
• Visible distended superficial veins

PE signs

• Sudden onset shortness of breath
• Pleuritic chest pain (worse with breathing)
• Tachycardia (rapid heart rate)
• Cough, sometimes with blood-tinged sputum
• Lightheadedness, syncope (collapse)

Any of these warrants immediate medical assessment — emergency department in most cases. PE is time-critical; delayed diagnosis increases mortality.

Quality markers — what to ask

• Caprini scoring used routinely? A surgeon should be able to identify this framework.
• Specific prophylaxis protocol — mechanical + chemical for typical risk profiles.
• Hormonal contraceptive guidance — should include 4-week pre-op cessation discussion.
• Post-discharge enoxaparin for higher-risk patients — extended prophylaxis is evidence-supported.
• Smoking cessation as VTE prevention component.
• Patient education on warning signs at discharge.

Frequently asked questions